Interface fluid syndrome secondary to endothelial failure due to toxic anterior segment syndrome after cataract surgery

Kasım, Burcu; Koçluk, Yusuf; Burcu, Ayşe

doi:10.1177/1120672118800241

Cited by 6 publications

(5 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11 The mainly related cause of IFS is increased intraocular pressure, but it may also be related to endothelial decompensation after several pathologies. 11–13 As the intraocular pressure has not increased, we believe that the immune-mediated endothelial rejection induced corneal edema and IFS.…”

Section: Discussionmentioning

confidence: 99%

Corneal Graft Rejection After Inactivated SARS-CoV-2 Vaccine: Case Report

Simão

Kwitko

2021

Cornea

View full text Add to dashboard Cite

Purpose:Our aim was to report the case of endothelial corneal allograft rejection after inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine with an atypical presentation.Methods:This was a case report.Results:A 63-year-old woman with previous penetrating keratoplasty and laser in situ keratomileusis presented with clinical signs of endothelial corneal graft rejection 24 hours after CoronaVac (SinoVac Biotech, Beijing/China) vaccine. Slitlamp examination showed corneal edema and interface fluid accumulation. It was partially resolved after treatment with topical corticosteroids and polydimethylsiloxane.Conclusions:Corneal allograft rejection was already reported after another SARS-CoV-2 vaccine. This is the first report in the literature describing a possible association with inactivated SARS-CoV-2 vaccine and corneal allograft rejection, especially with laser in situ keratomileusis interface fluid accumulation presentation. Ophthalmologists should be aware of this potential complication.

show abstract

Section: Discussionmentioning

confidence: 99%

Corneal Graft Rejection After Inactivated SARS-CoV-2 Vaccine: Case Report

Simão

Kwitko

2021

Cornea

View full text Add to dashboard Cite

show abstract

“…8,9 This is of concern because patients are frequently prescribed topical steroids after LASIK and other ophthalmic procedures. [10][11][12] These steroid-responsive patients are at risk of elevated IOP that drives fluid accumulation at the corneal interface, leading to IFS development. If IFS is not quickly identified along with steroid cessation, high IOP can lead to optic nerve damage, glaucomatous optic neuropathy, and rapid vision loss.…”

mentioning

confidence: 99%

“…3,4,6,7 There is no clear time course for IFS development, with symptoms appearing anywhere from 1 week after LASIK to many months or even years later. 4,12,14,16 Another issue with diagnosing IFS is falsely low IOP readings. The presence of a fluid pocket within the cornea can skew Goldmann applanation tonometry readings because of easy compression of the corneal flap that is superimposing the fluid.…”

mentioning

confidence: 99%

Interface fluid syndrome after LASIK surgery: retrospective pooled analysis and systematic review

Ravipati

Pradeep

Donaldson

2023

J Cataract Refract Surg

View full text Add to dashboard Cite

Interface fluid syndrome (IFS) is a complication associated with laser in situ keratomileusis (LASIK) surgery where a fluid pocket in the corneal stroma decreases visual acuity. A systematic review of IFS cases using PRISMA guidelines was performed yielding a total of 33 patients. 2 outcomes were selected for logistic regression analysis: final corrected distance visual acuity (CDVA) and need for surgical management. Results showed 33.3% of patients required surgery, 51.5% had their IFS resolve within 1 month or sooner, and 51.5% had final CDVA 20/25 or better. Higher presenting intraocular pressure (IOP) and duration of IFS ≤1 month was associated with higher odds of final CDVA 20/25 or better (adjusted odds ratio [aOR] 1.12, P = .04; aOR 7.71, P = .02, respectively). Endothelial cell dysfunction led to 17.55 greater odds for requiring surgical compared to medical management (aOR 0.36, P = .04). Presenting IOP and duration of IFS predicted final CDVA, while prior endothelial cell dysfunction predicted need for surgery.

show abstract

“…18 Two case reports showed favorable outcomes after DMEK in 2 patients with interface fluid syndrome secondary to endothelial decompensation because of TASS after cataract surgery in cases with previous LASIK surgery. 19,20 In this study, we retrospectively reviewed the outcomes of DMEK in 13 patients with corneal endothelial failure due to TASS. All grafts except 1 eye were clear at the last postoperative control, and these 12 eyes had better BCVA at the last visit than preoperative values.…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Descemet Membrane Endothelial Keratoplasty in Toxic Anterior Segment Syndrome: A Case Series

Necip

Oltulu

Levent

et al. 2020

Cornea

View full text Add to dashboard Cite

Purpose: To evaluate the outcomes of Descemet membrane endothelial keratoplasty (DMEK) in patients with toxic anterior segment syndrome (TASS).Methods: Thirteen eyes of 13 patients who underwent DMEK for endothelial decompensation secondary to TASS were retrospectively reviewed. A comprehensive ocular examination including bestcorrected visual acuity (BCVA), slitlamp biomicroscopy, intraocular pressure measurement, fundus evaluation, and measurement of central corneal thickness were performed in all patients at preoperatively and postoperatively.Results: There were 8 men and 5 women, with an average age of 56 6 19 years. The mean follow-up was 8.7 6 3.5 months. The time interval between the onset of TASS and DMEK was 4.9.66.6 months (range, 1.5-26 months). Twelve of 13 grafts were clear at last visit. The mean preoperative BCVA was 20/666 (range, hand motion to 20/ 200), and the mean BCVA was 20/36 (range, hand motion to 20/20) at the postoperative last visit (P = 0.003). The decrease in mean pachymetry from preoperative (768 6 69 mm) to postoperative last visit (523 6 71 mm) was statistically significant (P , 0.001).Conclusions: DMEK seems to be a safe and an effective treatment option in eyes with TASS-related endothelial decompensation.

show abstract

Interface fluid syndrome secondary to endothelial failure due to toxic anterior segment syndrome after cataract surgery

Cited by 6 publications

References 12 publications

Corneal Graft Rejection After Inactivated SARS-CoV-2 Vaccine: Case Report

Corneal Graft Rejection After Inactivated SARS-CoV-2 Vaccine: Case Report

Interface fluid syndrome after LASIK surgery: retrospective pooled analysis and systematic review

Descemet Membrane Endothelial Keratoplasty in Toxic Anterior Segment Syndrome: A Case Series

Contact Info

Product

Resources

About